We are live on
!
Find out more
PAWC
P.A.W. Capital Portfolio holdings
AUM
$131M
1-Year Est. Return
46.14%
This Fund
S&P 500
This Quarter
Est. Return
+4.93%
1 Year Est. Return
+46.14%
3 Year Est. Return
+67.18%
5 Year Est. Return
+64.85%
10 Year Est. Return
+1,459.33%
AUM
$83.2M
AUM Growth
+$3.73M
(+4.7%)
Cap. Flow
+$2.22M
Cap. Flow
% of AUM
2.67%
Top 10 Holdings %
Top 10 Hldgs %
40.86%
Holding
65
New
9
Increased
10
Reduced
26
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EFII
Electronics for Imaging
EFII
|
+$2.15M |
| 2 |
Gaia
GAIA
|
+$2.1M |
| 3 |
QUOT
Quotient Technology Inc
QUOT
|
+$886K |
| 4 |
Marchex
MCHX
|
+$646K |
| 5 |
Allot
ALLT
|
+$639K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CCXI
ChemoCentryx, Inc.
CCXI
|
+$877K |
| 2 |
CARB
Carbonite Inc
CARB
|
+$804K |
| 3 |
uniQure
QURE
|
+$763K |
| 4 |
Chegg
CHGG
|
+$757K |
| 5 |
CASC
Cascadian Therapeutics, Inc.
CASC
|
+$740K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.1% |
| 2 | Communication Services | 13.33% |
| 3 | Healthcare | 12.36% |
| 4 | Consumer Staples | 10.53% |
| 5 | Financials | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
AbbVie
ABBV
$443B
| $568K | 0.68% |
6,000
-1,500
| -20% | -$165K |
|
52
Galmed Pharmaceuticals
GLMD
$5.13M
| $557K | 0.67% |
556
-27
| -5% | -$39.3K |
|
53
GE Aerospace
GE
$374B
| $539K | 0.65% |
8,346
| – | – |
|
|
CELG
54
DELISTED
Celgene Corp
CELG
| $446K | 0.54% |
+5,000
| New | +$480K |
|
|
CLLS
55
Cellectis
CLLS
$277M
| $425K | 0.51% |
+13,500
| New | +$426K |
|
56
Cue Biopharma
CUE
$113M
| $422K | 0.51% |
+1,000
| New | +$456K |
|
57
Newell Brands
NWL
$2.38B
| $382K | 0.46% |
+15,000
| New | +$424K |
|
58
Macy's
M
$6.53B
| $297K | 0.36% |
10,000
-10,000
| -50% | -$270K |
|
59
Intel
INTC
$455B
| $208K | 0.25% |
+4,000
| New | +$190K |
|
60
Plains All American Pipeline
PAA
$17.3B
| – | – |
-20,000
| Closed | -$413K |
|
61
Under Armour Class C
UA
$2.77B
| – | – |
-30,000
| Closed | -$400K |
|
|
CASC
62
DELISTED
Cascadian Therapeutics, Inc.
CASC
| – | – |
-200,000
| Closed | -$740K |
|
Similar funds
EIM
CIP
AC
ADEF
LC
EWP
OIM
EPI
P.A.W. Capital's Q1 2018 Portfolio in Review
As of Q1 2018, P.A.W. Capital held 65 positions worth $83.2M, up 4.7% from $79.5M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
P.A.W. Capital's Q1 2018 filing shows 9 new, 10 increased, 26 reduced and 4 closed positions. Its largest new stake was Electronics for Imaging: 75,000 shares worth $2.05M. The largest sale was ChemoCentryx, Inc., an estimated $877K.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 32% a quarter earlier, followed by Communication Services and Healthcare.
- P.A.W. Capital's largest Q1 2018 buy was Electronics for Imaging: 75,000 shares worth $2.05M.
- P.A.W. Capital added most to Quotient Technology Inc in Q1 2018, an estimated $886K increase.
- P.A.W. Capital's biggest Q1 2018 reduction was ChemoCentryx, Inc., cutting an estimated $877K.
- P.A.W. Capital fully exited Cascadian Therapeutics, Inc. in Q1 2018, selling an estimated $740K.
- P.A.W. Capital's ten largest holdings make up 41% of its $83.2M portfolio in Q1 2018.
- P.A.W. Capital opened 9 new positions and closed 4 in Q1 2018.
- P.A.W. Capital's portfolio value rose 4.7% quarter-over-quarter to $83.2M.
Based on P.A.W. Capital's 13F filing for Q1 2018, filed 26 Apr 2018.